The University of Chicago Header Logo

Connection

Bruce Brockstein to Triazines

This is a "connection" page, showing publications Bruce Brockstein has written about Triazines.
Connection Strength

0.171
  1. Phase II randomised discontinuation trial of brivanib in patients with advanced solid tumours. Eur J Cancer. 2019 10; 120:132-139.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.